Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial.

MLA

Kabul, Samaneh, et al. “Patient-Reported Outcomes in Transition from High-Dose U-100 Insulin to Human Regular U-500 Insulin in Severely Insulin-Resistant Patients with Type 2 Diabetes: Analysis of a Randomized Clinical Trial.” Health & Quality of Life Outcomes, vol. 14, Sept. 2016, p. 139. EBSCOhost, https://doi.org/10.1186/s12955-016-0541-4.

APA

Kabul, S., Hood, R. C., Duan, R., DeLozier, A. M., & Settles, J. (2016). Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial. Health & Quality of Life Outcomes, 14, 139. https://doi.org/10.1186/s12955-016-0541-4

Chicago

Kabul, Samaneh, Robert C Hood, Ran Duan, Amy M DeLozier, and Julie Settles. 2016. “Patient-Reported Outcomes in Transition from High-Dose U-100 Insulin to Human Regular U-500 Insulin in Severely Insulin-Resistant Patients with Type 2 Diabetes: Analysis of a Randomized Clinical Trial.” Health & Quality of Life Outcomes 14 (September): 139. doi:10.1186/s12955-016-0541-4.